ARTICLE
7 January 2019

CMS Seeks Relaxation Of Kickback & Self-Referral Regulations

DP
Day Pitney LLP

Contributor

Day Pitney LLP logo
Day Pitney LLP is a full-service law firm with more than 300 attorneys in Boston, Connecticut, Florida, New Jersey, New York and Washington, DC. The firm offers clients strong corporate and litigation practices, with experience on behalf of large national and international corporations as well as emerging and middle-market companies. With one of the largest individual clients practices on the East Coast, the firm also has extensive experience assisting individuals and their families, fiduciaries and tax-exempt entities plan for the future.
The CMS recently published proposed changes to the Anti-Kickback Statute and Stark Law to address concerns that these laws are too restrictive and not current with modern healthcare and therefore are stifling innovation ...
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

The Centers for Medicare & Medicaid Services ("CMS") recently published proposed changes to the Anti-Kickback Statute and Stark Law to address concerns that these laws are too restrictive and not current with modern healthcare and therefore are stifling innovation and arrangements that may decrease health care costs. The goal of the proposed revisions is to encourage coordinated care, which would allow for more partnerships in the healthcare industry.

However, the risks of scaling back on the Anti-Kickback Statute or Stark Law are significant. These Federal healthcare regulations are designed to prohibit certain interactions amongst healthcare entities; yet despite such longstanding regulations, the Justice Department and other law enforcement agencies continue to expose schemes that exploit government health programs. More recently, the government has focused on the susceptibility of healthcare providers to be influenced by pharmaceutical companies and based on a study from 2017, roughly half of US doctors received payments from the drug industry, which represents nearly $2.5 billion in pharmaceutical company spending.

Any changes to the Anti-Kickback Statute or Stark Law will need to balance the need for more flexibility in models that coordinate care while prohibiting improper conduct that results in inappropriate payments or services. The Comment Period for these proposed changes closed on August 24,2018 and comments can be viewed on the Federal Register here.


For more articles and regular updates on legislative changes, regulatory developments and other news of interest to businesses, professionals and investors in the healthcare industry, please subscribe to Day Pitney's mailing lists.


Click here for more Healthcare Blogs from Day Pitney

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More